Beam is now in the strongest position of all companies advancing a genetic therapy for alpha-1 antitrypsin deficiency, according to analysts at William Blair. Beam Therapeutics’ investigational base ...

Data work in 2026 asks for more than chart building. Professionals are expected to clean data, query databases, explain trends, and present findings clearly across business, finance, product, and ...

Hamza is a gaming enthusiast and a Writing Specialist from Pakistan. A firm believer in Keyboard/Mouse supremacy, he will play Tekken with WASD if you let him. He has been writing about games since ...

The planned closure of Bio Palette has triggered the termination of a deal that gave Beam Therapeutics rights to base editing technology. Having prepared for that outcome, Beam has retained access to ...

BEAM-301, which is slightly behind 302 in terms of testing and approval progress, offers another indication for Beam’s base editing biotechnology platform. It aims to correct the R83C mutation in ...

While neutron irradiation requires a test reactor, ion irradiation can be done with ion accelerators in laboratories.University of Michigan Ion beams can now qualify nuclear reactor materials up to ...

Fred Beam is the deaf performing artist who will sign the national anthem and “Lift Every Voice and Sing” in American Sign Language at Super Bowl LX on February 8, 2026, at Levi’s Stadium in Santa ...

Nava Public Benefit Corp. has completed the acquisition of Beam, a cloud-based product used by government agencies to administer safety net, emergency aid and cash assistance programs. Be part of the ...

Few companies stand better poised than Beam Therapeutics to reap the first fruits of the FDA’s promised flexibility toward cell and gene therapies. The biotech is pioneering treatments based on base ...

Good afternoon. Thank you for joining us for another session at the 44th JPMorgan Healthcare Conference. I'm Brian Cheng, one of the senior biotech analysts here at the firm. On stage, we have the CEO ...